A new publication from UBC researchers and the Notch Therapeutics team reveals a novel computer modeling workflow for predicting CAR-T pharmacology and patient outcomes. Dr. Peter Zandstra, Director of the School for Biomedical Engineering (SBME) and Professor at the Michael Smith Laboratories, and Dr. Dan Kirouac, adjunct Professor with the SBME, are co-authors on the recent Nature Biotechnology publication. Both are part of the Notch Therapeutics team, Zandstra serving as Chief Scientific Officer and Kirouac as Director of Systems Biology. Read the press release below to learn more about their findings, the impact on cellular therapy technologies and the potential treatment of cancer.
